Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Eckels

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, Aedes aegyptiB R Miller, B J Beaty, T H Aitken, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
The association of enhancing antibodies with seroconversion in humans receiving a dengue-2 live-virus vaccineK H Eckels, S C Kliks, D R Dubois, et al.
Research in Microbiology|September 1, 1990
Expression of the envelope antigen of dengue virus in vaccine strains of SalmonellaS Cohen, C J Powell, D R Dubois, et al.
Journal of Virology|June 1, 1989
Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitisM Bray, B T Zhao, L Markoff, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|March 27, 2002
Nucleotide sequence of envelope protein of Japanese encephalitis virus SA14-14-2 adapted to vero cellsS P Hong, W D Yoo, R Putnak, et al.
Infection and Immunity|February 1, 1981
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipientsW H Bancroft, F H Top, K H Eckels, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1995
T cell activation in vivo by dengue virus infectionI Kurane, B L Innis, C H Hoke, et al.
Vaccine|December 1, 1988
Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human useK H Eckels, Y X Yu, D R Dubois, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1987
Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteersK T McKee, W H Bancroft, K H Eckels, et al.
The American Journal of Tropical Medicine and Hygiene|March 21, 1998
Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodiesM Simmons, K R Porter, J Escamilla, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, Aedes aegyptiB R Miller, B J Beaty, T H Aitken, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
The association of enhancing antibodies with seroconversion in humans receiving a dengue-2 live-virus vaccineK H Eckels, S C Kliks, D R Dubois, et al.
Research in Microbiology|September 1, 1990
Expression of the envelope antigen of dengue virus in vaccine strains of SalmonellaS Cohen, C J Powell, D R Dubois, et al.
Journal of Virology|June 1, 1989
Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitisM Bray, B T Zhao, L Markoff, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|March 27, 2002
Nucleotide sequence of envelope protein of Japanese encephalitis virus SA14-14-2 adapted to vero cellsS P Hong, W D Yoo, R Putnak, et al.
Infection and Immunity|February 1, 1981
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipientsW H Bancroft, F H Top, K H Eckels, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1995
T cell activation in vivo by dengue virus infectionI Kurane, B L Innis, C H Hoke, et al.
Vaccine|December 1, 1988
Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human useK H Eckels, Y X Yu, D R Dubois, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1987
Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteersK T McKee, W H Bancroft, K H Eckels, et al.
The American Journal of Tropical Medicine and Hygiene|March 21, 1998
Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodiesM Simmons, K R Porter, J Escamilla, et al.
Pageof 6